Ventas, Inc. $VTR is Lasalle Investment Management Securities LLC’s 5th Largest Position

Lasalle Investment Management Securities LLC boosted its position in shares of Ventas, Inc. (NYSE:VTR) by 1,135.1% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,552,880 shares of the real estate investment trust’s stock after purchasing an additional 1,427,151 shares during the quarter. Ventas makes up 4.3% of Lasalle Investment Management Securities LLC’s portfolio, making the stock its 5th biggest holding. Lasalle Investment Management Securities LLC’s holdings in Ventas were worth $108,686,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. NewEdge Advisors LLC increased its position in shares of Ventas by 856.1% in the first quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust’s stock valued at $545,000 after buying an additional 7,097 shares in the last quarter. Empowered Funds LLC grew its stake in Ventas by 6.8% in the 1st quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust’s stock valued at $576,000 after acquiring an additional 536 shares during the last quarter. Woodline Partners LP increased its holdings in Ventas by 46.8% during the 1st quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust’s stock valued at $2,532,000 after acquiring an additional 11,739 shares in the last quarter. Focus Partners Wealth increased its holdings in Ventas by 130.4% during the 1st quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust’s stock valued at $1,486,000 after acquiring an additional 12,233 shares in the last quarter. Finally, Envestnet Asset Management Inc. lifted its holdings in shares of Ventas by 19.0% in the second quarter. Envestnet Asset Management Inc. now owns 372,054 shares of the real estate investment trust’s stock valued at $23,489,000 after purchasing an additional 59,522 shares in the last quarter. Institutional investors and hedge funds own 94.18% of the company’s stock.

Insider Buying and Selling at Ventas

In related news, EVP Carey S. Roberts sold 35,532 shares of the stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $85.00, for a total transaction of $3,020,220.00. Following the completion of the sale, the executive vice president owned 72,755 shares of the company’s stock, valued at approximately $6,184,175. This represents a 32.81% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Debra A. Cafaro sold 10,322 shares of the stock in a transaction on Monday, February 2nd. The stock was sold at an average price of $77.66, for a total transaction of $801,606.52. Following the completion of the sale, the chief executive officer directly owned 1,114,034 shares of the company’s stock, valued at $86,515,880.44. The trade was a 0.92% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 86,106 shares of company stock worth $6,931,397 in the last quarter. 0.80% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

VTR has been the subject of a number of recent research reports. KeyCorp raised their price objective on shares of Ventas from $85.00 to $90.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 10th. Scotiabank increased their target price on Ventas from $74.00 to $80.00 and gave the company a “sector perform” rating in a report on Thursday, November 13th. Morgan Stanley set a $90.00 price target on Ventas in a report on Friday, February 13th. Citigroup upped their price objective on Ventas from $88.00 to $96.00 and gave the company a “buy” rating in a research report on Wednesday, February 11th. Finally, Wells Fargo & Company increased their price objective on Ventas from $80.00 to $88.00 and gave the company an “overweight” rating in a research note on Tuesday, November 25th. Thirteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $86.87.

Ventas Stock Down 0.1%

Shares of NYSE:VTR opened at $86.38 on Friday. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 1.03. The firm has a market cap of $41.03 billion, a price-to-earnings ratio of 159.96, a PEG ratio of 2.11 and a beta of 0.77. The stock’s 50-day moving average price is $80.00 and its two-hundred day moving average price is $75.12. Ventas, Inc. has a 12-month low of $60.15 and a 12-month high of $87.87.

Ventas (NYSE:VTR) last posted its quarterly earnings data on Thursday, February 5th. The real estate investment trust reported $0.15 EPS for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.74). Ventas had a net margin of 4.31% and a return on equity of 2.09%. The company had revenue of ($1,229.71) million for the quarter, compared to analyst estimates of $1.53 billion. During the same period in the prior year, the company earned $0.81 EPS. The company’s revenue was up 21.7% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. On average, research analysts forecast that Ventas, Inc. will post 3.4 EPS for the current year.

Ventas Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, April 16th. Shareholders of record on Tuesday, March 31st will be issued a $0.52 dividend. This is a boost from Ventas’s previous quarterly dividend of $0.48. The ex-dividend date is Tuesday, March 31st. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. Ventas’s dividend payout ratio (DPR) is 355.56%.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.